Search Results
COMMODORE: gilteritinib for the treatment of R/R FLT3-mutated AML
Mechanisms of gilteritinib resistance in FLT3-mutated AML
Gilteritinib for FLT3-Mutant AML
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated AML?
Gilteritinib in the Treatment of FLT3-mutated AML
Real-world analysis of gilteritinib for R/R FLT3-mutated AML
Azacitidine and venetoclax plus gilteritinib in the treatment of FLT3-mutated AML
Gilteritinib maintenance after allogeneic transplantation in FLT3-mutated AML
The promise of combining venetoclax with gilteritinib for the treatment of FLT3-mutated AML
Patient-reported outcomes in FLT3-mutated AML patients treated with gilteritinib plus azacitidine
ADMIRAL: gilteritinib for R/R FLT3-mutated AML
Treatment avenues for patients with R/R FLT3-mutated AML: optimizing FLT3 inhibitors
